公司資料
Nuvation Bio 股價、新聞與催化劑
- 股票代碼:
- NUVB
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
6.93 USD (+1.46%)
收盤價
最後更新: 2026年8月21日
1.71B USD
市值
股價為何變動
As of Aug 21, 2026, NUVB closed up 1.46% at $6.93. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Nuvation Bio is an oncology company developing targeted cancer therapies and other precision-oncology assets. Its strategy is to build a focused cancer pipeline with broad therapeutic potential.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Nuvation sits in specialty oncology biotechnology.
商業模式特徵
The business depends on clinical data, pipeline selection, and the ability to translate oncology programs into value.
生技產業定位
Nuvation is a catalyst-sensitive oncology company whose valuation will depend on clinical and strategic progress.
未來催化劑
- Nuvation Bio’s catalysts are taletrectinib and any regulatory or data update in ROS1-positive lung cancer. The market will care about whether the asset can keep building a real oncology franchise.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。